MSH|^~\&|ADM|ARH|||201910171415||ADT^A08|4083138|D|2.2|||AL|NE
EVN|A08|201910171415||||
PID|1|FHATVIG0010760|AB00008221|AB8109|PCSTEST^IPOC1||19530826|M|||1111111^^ABBOTSFORD^BC^C1W 2E3|||||||AB000453/19|
PV1|1|I|AB-2BAKER^AB2B-B2108^2|EL|||.HOSPITAL^Hospitalist^.^^^^^^^^^^XX|||MEDS||||||||IN|||||||||||||||||||||ARH|||||201908261534|
PV2||W^Ward|GALLSTONES
OBX|1|ST|1010.1^WEIGHT^CPT4||65.000||||||F
OBX|2|ST|1010.3^HEIGHT^CPT4||130.0||||||F
OBX|3|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20181030||||||F
OBX|4|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCSWP^BC Services With Photo||||||F
OBX|5|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|6|CE|ADM MDRO4^or Bangladesh in the last 12 months?^ADM||N^NO||||||F
OBX|7|CE|ADM MRSA2^correctional/shelter in the last 6 months?^ADM||N^NO||||||F
OBX|8|CE|AcADLWAT00^Wash type performed^ADM||5^Sink side in bathroom||||||F
OBX|9|CE|AcFTTYPE00^Footwear type^ADM||1^Non slip socks||||||F
OBX|10|CE|AcMOCARE03^Mouth care assistance^ADM||1^Unassisted||||||F
OBX|11|CE|AcTOASST02^Toileting assistance^ADM||3^1 person assist||||||F
OBX|12|CE|AcWAASST03^Washing assistance^ADM||2^Supervision||||||F
OBX|13|TX|AdADMDAT01^Admission date^ADM||20191019||||||F
OBX|14|TX|AdHCPNPC01^Notification method comment^ADM||||||||F
OBX|15|TX|AdMRPNMD00^MRP or physician notification method^ADM||||||||F
OBX|16|CE|AdREPREF00^Report received^ADM||1^In person||||||F
OBX|17|TX|AdREPRFR01^Report received from^ADM||test||||||F
OBX|18|CE|CaPARAMR00^Cardiovascular defined parameters^ADM||1^Within defined parameters||||||F
OBX|19|TX|CaPLDATE00^PIV Insertion date^ADM||20190905||||||F
OBX|20|TX|CmASPARO01^Treatment participation other^ADM||||||||F
OBX|21|TX|CmASPART01^Treatment participation^ADM||||||||F
OBX|22|TX|CmINTCOM00^Interpreter comment^ADM||||||||F
OBX|23|TX|EnDDRRSP00^Response from designated provider^ADM||||||||F
OBX|24|TX|EnITEMCO00^Item(s) of concern^ADM||||||||F
OBX|25|TX|EnITEMRP01^Item(s) of concern reported to (name and designation)^ADM||||||||F
OBX|26|CE|Gi00000800^Enteral feeding tube unclogging method^ADM||1^Warm water||||||F
OBX|27|TX|GiABGIRT00^Abdomen abdominal girth^ADM||30.00||||||F
OBX|28|TX|GiABINDT00^Abdominal feeding tube insertion date^ADM||20190904||||||F
OBX|29|TX|GiADULPH01^Gastric tube pH adult^ADM||5.0||||||F
OBX|30|CE|GiBALTYP00^Balloon gastrostomy type^ADM||1^Long shaft||||||F
OBX|31|TX|GiBALVOL00^Balloon gastrostomy initial volume^ADM||22.3||||||F
OBX|32|CE|GiCNMETH00^Feeding tube placement confirmation method^ADM||1^Radiology report||||||F
OBX|33|TX|GiCURLEN00^Feeding tube current external length^ADM||20.3||||||F
OBX|34|TX|GiEFT00101^pH duodenal tube^ADM||8.0||||||F
OBX|35|CE|GiEFT00300^Site appearance^ADM||1^Redness||||||F
OBX|36|TX|GiEFT00400^Site appearance other^ADM||test||||||F
OBX|37|CE|GiEFT00500^Exudate description^ADM||1^Serous||||||F
OBX|38|TX|GiEFT00700^Balloon volume removed^ADM||10||||||F
OBX|39|TX|GiEFT00800^Balloon volume filled^ADM||10||||||F
OBX|40|TX|GiENTINS00^Enteral feeding tube length at insertion^ADM||35.536666||||||F
OBX|41|TX|GiETCLON01^Enteral feeding tube number of unclogging attempts^ADM||3||||||F
OBX|42|TX|GiETCLOT00^Enteral feeding tube unclogging method other^ADM||test||||||F
OBX|43|TX|GiETCOMM02^Other enteral feeding tube comments^ADM||test||||||F
OBX|44|TX|GiETDEVI00^Enteral feeding tube securement device intact^ADM||Y||||||F
OBX|45|TX|GiETDEVI01^Enteral feeding tube securement device intact^ADM||Y||||||F
OBX|46|TX|GiETINAT00^Enteral feeding tube insertion attempts^ADM||3||||||F
OBX|47|TX|GiETPLCO00^Enteral tube placement comments^ADM||test||||||F
OBX|48|TX|GiETREMD00^Enteral feeding tube removal date^ADM||20190904||||||F
OBX|49|CE|GiETREMR03^Enteral feeding tube removal reason^ADM||2^Oral intake adequate||||||F
OBX|50|TX|GiETSIZE00^Enteral feeding tube size^ADM||14.0||||||F
OBX|51|TX|GiEXLNTH00^Feeding tube initial external length^ADM||620.3||||||F
OBX|52|CE|GiFTTYPE00^Feeding tube type^ADM||3^Gastrostomy||||||F
OBX|53|TX|GiGT000300^Enteral feeding tube current length^ADM||2.5||||||F
OBX|54|TX|GiGT000700^Other insertion comments^ADM||test||||||F
OBX|55|CE|GiGT000900^Gastric tube port status^ADM||1^Draining to gravity||||||F
OBX|56|CE|GiGT001000^Jejunal tube port status^ADM||3^Feeding||||||F
OBX|57|TX|GiGTREAD01^Gastric drainage description other^ADM||test||||||F
OBX|58|CE|GiGTRECH00^Gastric return characteristics^ADM||1^Green||||||F
OBX|59|TX|GiNOINDT00^Nasal/Oral feeding tube insertion date^ADM||20190904||||||F
OBX|60|CE|GiNSORAL01^Feeding tube insertion site^ADM||1^Right nare||||||F
OBX|61|CE|GiPARAMR00^Gastrointestinal defined parameters^ADM||1^Within defined parameters||||||F
OBX|62|TX|GiREPLCD00^Abdominal feeding tube scheduled replacement date^ADM||20190925||||||F
OBX|63|TX|GiREPORT01^Enteral feeding tube reported placement^ADM||es||||||F
OBX|64|TX|GiSECURE00^Securement method^ADM||test||||||F
OBX|65|TX|GiSKINNT00^Surrounding skin intact^ADM||N||||||F
OBX|66|TX|GiTBRAND00^Feeding tube brand^ADM||test||||||F
OBX|67|TX|GiTUBEBL00^Tube balloon volume checked^ADM||Y||||||F
OBX|68|TX|GiTUBERT00^Tube rotated^ADM||Y||||||F
OBX|69|CE|GuBDVM0002^Voiding method^ADM||4^Self-catheterization~6^Bed pan||||||F
OBX|70|CE|GuPARAMR00^Genitourinary defined parameters^ADM||1^Within defined parameters||||||F
OBX|71|TX|GuPD000100^Dialysate 1 volume^ADM||1000||||||F
OBX|72|TX|GuPD000200^Dialysate 2 volume^ADM||1000||||||F
OBX|73|TX|GuPD000300^Dialysate 3 volume^ADM||500||||||F
OBX|74|CE|GuPD000401^Prescription verified^ADM||1^At set-up||||||F
OBX|75|CE|GuPD000500^Dialysate 1 type^ADM||1^Dextrose||||||F
OBX|76|CE|GuPD000600^Dialysate 1 concentration^ADM||1^1.5%||||||F
OBX|77|CE|GuPD000700^Dialysate 2 type^ADM||1^Dextrose||||||F
OBX|78|CE|GuPD000800^Dialysate 2 concentration^ADM||1^1.5%||||||F
OBX|79|CE|GuPD000900^Dialysate 3 type^ADM||1^Dextrose||||||F
OBX|80|CE|GuPD001000^Dialysate 3 concentration^ADM||1^1.5%||||||F
OBX|81|CE|GuPD001100^Dialysate last fill type^ADM||1^Dextrose||||||F
OBX|82|CE|GuPD001200^Dialysate last fill concentration^ADM||1^7.5%||||||F
OBX|83|TX|GuPD001300^Dialysate last fill volume^ADM||5400||||||F
OBX|84|TX|GuPD001400^Time continuous cycling peritoneal dialysis initiated^ADM||1000||||||F
OBX|85|TX|GuPD001500^Output, Peritoneal Dialysate Initial Drain Amount^ADM||1000||||||F
OBX|86|TX|GuPD001600^Total ultrafiltration^ADM||5||||||F
OBX|87|TX|GuPD001700^Dwell average time^ADM||54||||||F
OBX|88|TX|GuPD001800^Dwell added time^ADM||5||||||F
OBX|89|TX|GuPD001900^Dwell lost time^ADM||5||||||F
OBX|90|TX|GuPD002000^Dwell comments^ADM||test||||||F
OBX|91|TX|GuPD002200^Number of alarm(s) during therapy^ADM||5||||||F
OBX|92|TX|GuPD002300^Type of alarm(s) during therapy other^ADM||test||||||F
OBX|93|TX|GuPD002400^Alarm(s) comments^ADM||test||||||F
OBX|94|TX|GuPD002500^Intake, Peritoneal Dialysate Last Fill Amount^ADM||500||||||F
OBX|95|CE|GuPD002600^Type of alarm(s) during therapy^ADM||1^Check drain line||||||F
OBX|96|TX|GuPDCEDO00^Peritoneal dialysis catheter exit site drainage other^ADM||test||||||F
OBX|97|CE|GuPDCESA00^Peritoneal dialysis catheter exit site appearance^ADM||1^Satisfactory||||||F
OBX|98|CE|GuPDCESD00^Peritoneal dialysis catheter exit site drainage^ADM||1^None||||||F
OBX|99|TX|GuPDCESO00^Peritoneal dialysis catheter exit site appearance other^ADM||test||||||F
OBX|100|CE|GuPDCLOC00^Peritoneal dialysis catheter location^ADM||3^Right upper quadrant||||||F
OBX|101|TX|GuPDCMT000^Other peritoneal dialysis comments^ADM||test||||||F
OBX|102|CE|GuPDDCL000^Peritoneal dialysis dialysate clarity^ADM||1^Clear||||||F
OBX|103|TX|GuPDDCLO00^Peritoneal dialysis dialysate clarity other^ADM||test||||||F
OBX|104|TX|GuPDFLS000^Fluid leakage from site^ADM||Y||||||F
OBX|105|TX|GuPDMAD000^Peritoneal dialysis medications added to dialysate^ADM||Y||||||F
OBX|106|TX|GuPDSDIO00^Peritoneal dialysis securement device in use other^ADM||test||||||F
OBX|107|CE|GuPDSDIU01^Peritoneal dialysis securement device in use^ADM||1^Tape||||||F
OBX|108|TX|GuUCBFV000^Urinary catheter balloon fill volume^ADM||10||||||F
OBX|109|CE|GuUCBSZ000^Urinary catheter balloon size^ADM||4^30 cc||||||F
OBX|110|TX|GuUCIARO00^Urinary catheter insertion/application reason other^ADM||long-term||||||F
OBX|111|TX|GuUCID0000^Urinary catheter insertion date^ADM||20190827||||||F
OBX|112|CE|GuUCMAT000^Urinary catheter material^ADM||2^Silicone||||||F
OBX|113|TX|GuUCNIA000^Urinary catheter insertion attempts^ADM||1||||||F
OBX|114|TX|GuUCSDU000^Urinary catheter securement device in use^ADM||Y||||||F
OBX|115|CE|GuUCSZA001^Urinary catheter size^ADM||3^14 Fr||||||F
OBX|116|CE|GuUCTL0000^Urinary catheter type/location^ADM||2^2-way||||||F
OBX|117|CE|GuUCUCS000^Urinary collection system^ADM||1^Drainage bag||||||F
OBX|118|CE|GuURCLR000^Urine clarity^ADM||1^Clear||||||F
OBX|119|CE|GuURCOL001^Urine colour^ADM||1^Yellow||||||F
OBX|120|CE|GuURCOL002^Urine colour^ADM||1^Yellow||||||F
OBX|121|TX|GuUROA0000^Urine output adequate^ADM||Y||||||F
OBX|122|CE|GuUROD0000^Urine odour^ADM||1^None||||||F
OBX|123|CE|HeAXPAR000^Assessment participation^ADM||1^No concerns||||||F
OBX|124|TX|HeAXPARC01^Assessment participation comments^ADM||test||||||F
OBX|125|TX|HeAXPARO01^Assessment participation other^ADM||test||||||F
OBX|126|TX|HeSLP01001^Treatment participation comments^ADM||||||||F
OBX|127|TX|HeTR000100^Trachea position^ADM||||||||F
OBX|128|TX|InDR000200^Type of dressing applied^ADM||test||||||F
OBX|129|CE|InDRATYE00^Drainage type^ADM||1^Serous||||||F
OBX|130|TX|InDRESSC00^Dressing changed^ADM||Y||||||F
OBX|131|TX|InDRESSP00^Dressing present^ADM||Y||||||F
OBX|132|CE|InDREWOU00^Wound cleansing solution^ADM||1^Sterile normal saline||||||F
OBX|133|TX|InINDRES00^Dressing dry and intact^ADM||Y||||||F
OBX|134|CE|InISGR0000^infiltration Scale Grade^ADM||1^0||||||F
OBX|135|TX|InNAREIN00^Nares skin intact^ADM||Y||||||F
OBX|136|CE|InPARAMR00^Integumentary defined parameters^ADM||1^Within defined parameters||||||F
OBX|137|CE|InPESIDE00^Peripheral line site description^ADM||1^Satisfactory||||||F
OBX|138|TX|InPTRESP00^Patient's response to procedure^ADM|| ~tolerated well||||||F
OBX|139|TX|InSITECL00^Site cleansed^ADM||Y||||||F
OBX|140|TX|InSUTDAT00^Sutures scheduled removal date^ADM||20190928||||||F
OBX|141|TX|InSUTPRE00^Sutures present^ADM||Y||||||F
OBX|142|TX|IoNICUIN20^Location^ADM||lt arm||||||F
OBX|143|TX|IoNICUIN30^Intake, IV Amount^ADM||50.00||||||F
OBX|144|CE|IoSOLUMA00^Solution^ADM||15^Insulin||||||F
OBX|145|CE|IvLOCATM01^Location Modifier^ADM||5^Left||||||F
OBX|146|CE|IvPIVLOC00^Location^ADM||2^Lower arm PIV||||||F
OBX|147|TX|IvPIVNIC00^PIV insertion time^ADM||1338||||||F
OBX|148|CE|IvPL000700^Initial management^ADM||1^Infusion||||||F
OBX|149|CE|IvPS000100^Phlebitis scale grade^ADM||1^0||||||F
OBX|150|TX|IvRATE0000^Rate^ADM||10.00||||||F
OBX|151|TX|IvSIZE0000^Size^ADM||22||||||F
OBX|152|CE|MhPED00100^Behaviour^ADM||1^Relaxed||||||F
OBX|153|CE|Mo00000501^Ambulation support provided^ADM||2^Supervision||||||F
OBX|154|CE|MoAIDAMB00^Ambulation aid^ADM||9^Walker: 2 wheeled||||||F
OBX|155|CE|MoAIDTRA00^Transfer aid^ADM||1^No aid used||||||F
OBX|156|CE|MoAMBLOC00^Ambulation location^ADM||1^Within room||||||F
OBX|157|CE|MoAMMBAD01^Ambulation aid^ADM||1^Standard walker||||||F
OBX|158|TX|MoAOTOHC00^Other task outcome comments^ADM||||||||F
OBX|159|TX|MoCHTIME04^Duration of time up in chair^ADM||60||||||F
OBX|160|CE|MoEQUTRA00^Transfer equipment^ADM||1^No equipment used||||||F
OBX|161|CE|MoEXERB00^Exercises in bed^ADM||1^UE ROM~2^LE ROM||||||F
OBX|162|TX|MoEXERBC00^Bed exercises completed^ADM||Y||||||F
OBX|163|CE|MoFA000001^Fall prevention strategies^ADM||1^Universal~2^Chair alarm~9^Bed alarm~10^Hip protectors~14^Mobility aid accessible~18^Monitor while mobilizing||||||F
OBX|164|CE|MoFAM00002^Additional fall prevention strategies^ADM||9^Non-slip socks||||||F
OBX|165|CE|MoMOTYPE00^Mobility type^ADM||1^Bed mobility||||||F
OBX|166|TX|MoMOTYPT00^Mobility type^ADM||||||||F
OBX|167|CE|MoPOBDPO01^Bed position^ADM||4^Low fowlers (30-45 deg)||||||F
OBX|168|CE|MoRECEQP00^Recommended equipment^ADM||6^Bed rail||||||F
OBX|169|TX|MoSUPPPT00^Recommended support provided^ADM||||||||F
OBX|170|CE|MoSUPPRV00^Recommended support provided^ADM||1^None||||||F
OBX|171|CE|MoTRANSF00^Transfer from^ADM||1^Bed||||||F
OBX|172|CE|MoTRANST02^Transfer to^ADM||2^Chair||||||F
OBX|173|CE|MoTRSUP001^Transfer support provided^ADM||2^Supervision||||||F
OBX|174|CE|MsORTH0003^Supportive orthosis for mobilization^ADM||6^Shoulder sling~7^Air cast||||||F
OBX|175|CE|NeLECONS00^Level of consciousness^ADM||1^Alert||||||F
OBX|176|CE|NeORIENT01^Oriented to^ADM||1^All domains||||||F
OBX|177|CE|NePARAMR00^Neurological and cognition defined parameters^ADM||1^Within defined parameters||||||F
OBX|178|TX|NuEN000100^Enteral feeding tube patent after treatment^ADM||Y||||||F
OBX|179|TX|NuOGRETU01^Output, Gastric Drainage Amount^ADM||10.00||||||F
OBX|180|TX|NuOURINE00^Output - urine^ADM||500.00||||||F
OBX|181|TX|Oh00000800^Care plan^ADM||||||||F
OBX|182|TX|OhEDIT0000^Reason for edit^ADM||test||||||F
OBX|183|TX|OhINTE0001^Type of interpreter^ADM||||||||F
OBX|184|CE|PaFREQ0000^Pain frequency^ADM||2^With movement||||||F
OBX|185|CE|PaLOCBDS02^Location^ADM||4^Neck||||||F
OBX|186|CE|PaPAIASS00^Pain assessment^ADM||2^Pain reported||||||F
OBX|187|CE|PaPALOCM00^Pain location modifier^ADM||7^Anterior||||||F
OBX|188|CE|PaPAQUAL01^Pain quality^ADM||4^Ache||||||F
OBX|189|TX|PaPARADI00^Pain radiating^ADM||N||||||F
OBX|190|CE|PaPARAMR00^Pain defined parameters^ADM||1^Within defined parameters||||||F
OBX|191|TX|PaPATIME00^Time of pain onset^ADM||1330||||||F
OBX|192|CE|PaPATYPE00^Pain type of onset^ADM||1^Gradual||||||F
OBX|193|CE|PaPNMGTT00^Pain management techniques^ADM||1^Medication||||||F
OBX|194|CE|PsCCIMP000^Cognitive communication impairments^ADM||1^Attention~4^Memory~5^Organization||||||F
OBX|195|TX|PsCCIMPO00^Cognitive communication impairments other^ADM||test||||||F
OBX|196|TX|PsCOMPRL00^Communication primary language^ADM||||||||F
OBX|197|CE|PsPARAMR00^Psychosocial and mood defined parameters^ADM||1^Within defined parameters||||||F
OBX|198|TX|PsRCCOCO01^Cognitive communication comments^ADM||test||||||F
OBX|199|TX|Re00000000^Respiratory pre-hospital baseline^ADM||||||||F
OBX|200|TX|Re00000100^Respiratory assessment^ADM||||||||F
OBX|201|TX|ReABNORM00^Abnormal findings comments^ADM||||||||F
OBX|202|TX|ReAENTRY00^Air entry adequate throughout^ADM||||||||F
OBX|203|TX|ReAUAIRE01^Air entry^ADM||||||||F
OBX|204|TX|ReAUBTHS02^Breath sounds^ADM||||||||F
OBX|205|TX|ReAULOCT00^Auscultation location^ADM||||||||F
OBX|206|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||||||||F
OBX|207|TX|ReBRESOU00^Breath sounds other^ADM||||||||F
OBX|208|TX|ReCGDESC01^Cough description^ADM||||||||F
OBX|209|TX|ReCGDESO00^Cough description other^ADM||||||||F
OBX|210|TX|ReCGPROD00^Cough productive^ADM||||||||F
OBX|211|TX|ReCGSTGH00^Cough strength^ADM||||||||F
OBX|212|TX|ReCOLMET01^Secretions collection method^ADM||||||||F
OBX|213|TX|ReDISTRE00^Respiratory distress comments^ADM||||||||F
OBX|214|TX|ReFIND0000^Other respiratory findings^ADM||||||||F
OBX|215|CE|ReOXYTHE04^Oxygen therapy delivery method^ADM||1^Room air||||||F
OBX|216|CE|RePARAMR00^Respiratory defined parameters^ADM||2^Significant findings||||||F
OBX|217|TX|RePHASE000^Phase^ADM||||||||F
OBX|218|TX|ReRECHEX01^Chest expansion^ADM||||||||F
OBX|219|TX|ReREDISI00^Respiratory distress indicators^ADM||||||||F
OBX|220|TX|ReREDISO00^Respiratory distress indicators other^ADM||||||||F
OBX|221|TX|ReREDPTH00^Respiratory depth^ADM||||||||F
OBX|222|TX|ReRPNM0000^Respiratory pattern^ADM||||||||F
OBX|223|TX|ReSCAMNT00^Secretions amount^ADM||||||||F
OBX|224|TX|ReSCCOLR00^Secretions colour^ADM||||||||F
OBX|225|TX|ReSCDESC02^Secretions description^ADM||||||||F
OBX|226|TX|ReSCDESO00^Secretions description other^ADM||||||||F
OBX|227|TX|ReSE000100^Secretion source^ADM||||||||F
OBX|228|TX|ReSECCOM00^Secretions comments^ADM||||||||F
OBX|229|TX|ReSECMET00^Secretions collection method other^ADM||||||||F
OBX|230|TX|ReSECRET00^Secretions source^ADM||||||||F
OBX|231|TX|ReWRKBRE00^Work of breathing^ADM||||||||F
OBX|232|TX|SpCONCOM01^Consent comments^ADM||||||||F
OBX|233|TX|SpCONOTH00^Assessment/Treatment benefits and risks explained to other^ADM||||||||F
OBX|234|TX|SpCONPAT00^Consent received from patient^ADM||||||||F
OBX|235|TX|SpCONRIS00^Assessment/Treatment benefits and risks explained to^ADM||||||||F
OBX|236|TX|SpCONSIG00^Consent for treatment received from^ADM||||||||F
OBX|237|TX|SpCONTYP00^Consent received for^ADM||||||||F
OBX|238|TX|SpTRAMAT11^Ensured universal fall prevention strategies in place^ADM||Y||||||F
OBX|239|TX|TeASRECO01^Communication assistance recommendations^ADM||||||||F
OBX|240|TX|TeDYSASR00^Dysphagia assistance recommendations^ADM||||||||F
OBX|241|TX|TeEDINTR00^Interpreter utilized^ADM||||||||F
OBX|242|TX|TeSL001000^Dysphagia therapy and tasks for support personnel^ADM||||||||F
OBX|243|TX|TeSL001100^Communication therapy and tasks for support personnel^ADM||||||||F
OBX|244|TX|TeTASKO000^Therapy and tasks outcome^ADM||||||||F
OBX|245|TX|TeTASKOC00^Therapy and task outcome comments^ADM||||||||F
OBX|246|CE|VsBPCFLP01^Blood pressure cuff location^ADM||1^Right arm||||||F
OBX|247|CE|VsBPDEUS00^Device used^ADM||1^Automated cuff||||||F
OBX|248|TX|VsBPDIAO01^Blood pressure diastolic^ADM||80||||||F
OBX|249|TX|VsBPMAPA03^Blood pressure mean arterial pressure^ADM||90||||||F
OBX|250|CE|VsBPPOST02^Patient position^ADM||2^Supine||||||F
OBX|251|TX|VsBPSYSO01^Blood pressure systolic^ADM||120||||||F
OBX|252|TX|VsHRADLT01^Heart rate^ADM||80||||||F
OBX|253|CE|VsHRMETH00^Heart rate method used^ADM||1^Palpation||||||F
OBX|254|CE|VsHRRHYM02^Pulse rhythm^ADM||1^Regular||||||F
OBX|255|TX|VsPOOSAD00^Pulse oximetry oxygen saturation^ADM||95||||||F
OBX|256|CE|VsPULSTR00^Pulse strength on palpation^ADM||2^Moderate||||||F
OBX|257|TX|VsRESPAD03^Respiratory rate^ADM||16||||||F
OBX|258|CE|VsTPSORC03^Temperature source^ADM||2^Oral||||||F
OBX|259|TX|VsTPTEMPO2^Temperature^ADM||37.0||||||F
OBX|260|TX|VsWT000101^Current Weight^ADM||55.000||||||F
OBX|261|TX|VsWT003500^Goal/target weight^ADM||50.000||||||F
OBX|262|TX|VsWTGRAM00^Weight (Calculated Grams)^ADM||55000.000||||||F
ZFD|.HOSPITAL^Hospitalist^.^^^^^^HOS||||.HOSPITAL^Hospitalist^.^^^^^^HOS|.HOSPITAL^Hospitalist^.^^^^^^HOS|
ZFH|LUMED||||||

